Financial Exposure After a Sealed-Source Release: Insurance Limits, Federal Cost Pathways, and Implications for Gamma Irradiator Substitution
This report assesses whether private insurance and existing federal authorities would likely provide meaningful financial protection to private operators of self-shielded gamma irradiators after a major sealed-source release. It does not answer this question quantitatively because publicly observable data on premiums, limits, uptake, and claims outcomes for this risk class appear sparse. Instead, it uses a qualitative structural analysis based on prior literature, review of relevant federal authorities, limited observable insurance-market evidence, expert outreach, and historical analogs. The analysis finds that available public and private mechanisms do not combine into a clear, dependable, or readily verifiable compensation structure for ordinary private sealed-source operators. Institutions therefore should not assume that either insurance or government response will make them financially whole after a severe incident. Source reduction and replacement remain more dependable than post-event financial mechanisms for reducing institutional exposure and broader radiological risk.